Bioisosteres in De Novo Design

[1]  K. Stewart,et al.  Drug Guru: a computer software program for drug design using medicinal chemistry rules. , 2006, Bioorganic & medicinal chemistry.

[2]  Olivier Michielin,et al.  SwissBioisostere: a database of molecular replacements for ligand design , 2012, Nucleic Acids Res..

[3]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[4]  P Ertl,et al.  World Wide Web-based system for the calculation of substituent parameters and substituent similarity searches. , 1998, Journal of molecular graphics & modelling.

[5]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[6]  Philip M. Dean,et al.  Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design , 1997, J. Comput. Aided Mol. Des..

[7]  Ajay,et al.  Kinase patent space visualization using chemical replacements. , 2006, Journal of medicinal chemistry.

[8]  Andrew G. Leach,et al.  Matched molecular pairs as a guide in the optimization of pharmaceutical properties; a study of aqueous solubility, plasma protein binding and oral exposure. , 2006, Journal of medicinal chemistry.

[9]  Peter Ertl,et al.  IADE: a system for intelligent automatic design of bioisosteric analogs , 2012, Journal of Computer-Aided Molecular Design.

[10]  Gerhard Klebe,et al.  Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..

[11]  J. Thornton,et al.  Shape variation in protein binding pockets and their ligands. , 2007, Journal of molecular biology.

[12]  Anne Mai Wassermann,et al.  Large-scale exploration of bioisosteric replacements on the basis of matched molecular pairs. , 2011, Future medicinal chemistry.

[13]  I. Langmuir ISOMORPHISM, ISOSTERISM AND COVALENCE. , 1919 .

[14]  Peter Ertl,et al.  Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization , 2010, Molecular informatics.

[15]  A Burger,et al.  Isosterism and bioisosterism in drug design. , 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[16]  Philip M Dean,et al.  Scaffold hopping in de novo design. Ligand generation in the absence of receptor information. , 2004, Journal of medicinal chemistry.

[17]  Peter Ertl,et al.  Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups , 2003, J. Chem. Inf. Comput. Sci..

[18]  F. Allen The Cambridge Structural Database: a quarter of a million crystal structures and rising. , 2002, Acta crystallographica. Section B, Structural science.

[19]  Toshio Fujita,et al.  Concept and features of EMIL, a system for lead evolution of bioactive compounds , 1993 .

[20]  Jameed Hussain,et al.  Computationally Efficient Algorithm to Identify Matched Molecular Pairs (MMPs) in Large Data Sets , 2010, J. Chem. Inf. Model..

[21]  Peter Ertl,et al.  Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions , 2009, J. Cheminformatics.

[22]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[23]  Nathan Brown,et al.  Bioisosteres in Medicinal Chemistry: BROWN:BIOISOSTERES MED CH O-BK , 2012 .

[24]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[25]  A. Ghose,et al.  A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. , 1999, Journal of combinatorial chemistry.

[26]  István Ujváry,et al.  Extended Summary: BIOSTER—a database of structurally analogous compounds , 1997 .

[27]  Markus Wagener,et al.  The Quest for Bioisosteric Replacements , 2006, J. Chem. Inf. Model..

[28]  P. N. Craig,et al.  Interdependence between physical parameters and selection of substituent groups for correlation studies. , 1971, Journal of medicinal chemistry.

[29]  C. Thornber,et al.  Isosterism and molecular modification in drug design , 1979 .

[30]  Nathan J. Brown Algorithms for chemoinformatics , 2011 .

[31]  Ajay N. Jain,et al.  Molecular Shape and Medicinal Chemistry: A Perspective , 2010, Journal of medicinal chemistry.

[32]  David Weininger,et al.  SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules , 1988, J. Chem. Inf. Comput. Sci..